Email me when Laurence W. Lytton files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| LIQT | LIQTECH INTERNATIONAL INC | Common Stock | 9.99% | $2.78M | 1.06M | Lytton-Kambara Foundation | Sep 30, 2025 | ||
| AYTU | AYTU BIOPHARMA, INC | Common Stock | 9.99% | $2.17M | $1.16M | 1.09M | +114% | LYTTON LAURENCE W | Sep 30, 2025 |
| GUER | GUERRILLA RF, INC. | Common Stock | 9.99% | $1.11M | 1.09M | Lytton, Laurence W. | Mar 28, 2024 | ||
| APRE | Aprea Therapeutics, Inc. | Common Stock | 9.9% | $914K | 682K | LYTTON LAURENCE W | Nov 13, 2025 | ||
| CLRB | Cellectar Biosciences, Inc. | Common Stock | 8.8% | $1.15M | 3.96M | LYTTON LAURENCE W | Dec 31, 2024 | ||
| TLPH | TALPHERA, INC. | Common Stock | 8% | $2.04M | 3.64M | LYTTON LAURENCE W | Sep 10, 2025 | ||
| SONM | SONIM TECHNOLOGIES INC | Common Stock | 7.8% | $48.3K | -$548K | 79.9K | -91.9% | LYTTON LAURENCE W | Sep 30, 2025 |
| TELA | TELA Bio, Inc. | Common Stock | 7.2% | $4.27M | -$833K | 2.87M | -16.3% | Lytton, Laurence W. | Sep 30, 2025 |
| XTNT | Xtant Medical Holdings, Inc. | Common Stock | 6.8% | $4.54M | 9.46M | Laurence W. Lytton | Apr 15, 2025 | ||
| MDXH | MDxHealth SA | Ordinary Shares | 6.4% | $14.7M | -$3.66M | 3.16M | -19.9% | LYTTON LAURENCE W | Sep 30, 2025 |
| CREX | CREATIVE REALITIES, INC. | Common Stock | 5.1% | $1.22M | $213K | 534K | +21.1% | LYTTON LAURENCE W | Oct 28, 2025 |
| DUOT | DUOS TECHNOLOGIES GROUP, INC. | Common Stock | 4.99% | $2.73M | 427K | LYTTON LAURENCE W | Jan 31, 2024 | ||
| SMTK | SmartKem, Inc. | Common Stock | 4.9% | $526K | -$261K | 223K | -33.2% | Lytton, Laurence W. | Mar 31, 2025 |
| ELVA | Electrovaya Inc. | Common Shares | 4.7% | $7.27M | -$2.09M | 1.9M | -22.3% | Lytton, Laurence W. | Jun 30, 2025 |
| EVOK | Evoke Pharma Inc | Common Stock, par value $0.0001 | 3.9% | $158K | 61.3K | Lytton, Laurence W. | Mar 31, 2025 | ||
| BFRI | Biofrontera Inc. | Common Stock, par value $0.001 | 3.5% | $255K | 307K | LYTTON LAURENCE W | Mar 31, 2025 | ||
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | Common Stock, par value $0.001 | 2.6% | $764K | 1.3M | LYTTON LAURENCE W | Mar 31, 2025 | ||
| CLRB | Cellectar Biosciences, Inc. | Common Stock | 1.6% | $251K | 51.4K | LYTTON LAURENCE W | Jun 30, 2025 | ||
| EMKR | EMCORE CORP | Common Stock | 1.4% | $395K | 127K | LYTTON LAURENCE W | Dec 31, 2024 | ||
| XGN | EXAGEN INC. | Common Stock, par value $0.001 per share | 1% | $1.48M | 217K | LYTTON LAURENCE W | Jun 30, 2025 | ||
| SCPH | scPharmaceuticals Inc. | Common Stock | 0% | $0 | 0 | LYTTON LAURENCE W | Sep 30, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|